Role of Nasopharyngeal Airway in Management of Craniofacial Syndrome‐Associated Upper Airway Obstruction in Children
Orthodontics & Craniofacial Research · 2024
DOI: 10.1111/ocr.12872 ↗Kurz gefasst
Fachartikel in der Zeitschrift Orthodontics & Craniofacial Research, 2024. Verfasst von Samara Thambar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Respiratory and Sleep Medicine, Queensland Children's Hospital, South Brisbane, Australia. Hauptthemen laut MEDLINE: Airway Obstruction, Nasopharynx, Craniofacial Abnormalities, Airway Management. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Upper airway obstruction (UAO) management in children, particularly those with associated anatomical mid‐face structural differences, poses a significant challenge. This study describes using a nasopharyngeal airway (NPA) in managing infants with severe upper airway obstruction.
Methods
Infants discharged home from Queensland Children's Hospital with an NPA in situ for the management of upper airway obstruction were retrospectively evaluated for clinical and demographic parameters, underlying diagnoses and respiratory support, including NPA insertion details and comorbidities.
Results
Sixty‐seven children (24 male) were included with a median age at NPA insertion of 24 (IQR 7‐59) days and a median duration of NPA use of 229.1 (IQR 151.50‐297.75) days. Fifty‐two (77.6%) had Pierre Robin sequence. Other diagnoses included CHARGE syndrome, Treacher Collins syndrome, Stickler syndrome, Crouzon syndrome, Bohring–Opitz syndrome, isolated cleft palate, Beckwith–Wiedemann syndrome, Chromosome 3 deletion and VACTERL association. Four infants required tracheostomy, and no complications related to NPA use were reported. Those with oximetry and polysomnography data showed improving indices following NPA insertion [pre NPA median (IQR) SpO 2 : 95.9% (94.73–97.73), AHI: 51.40 (44.50‐69.45), OAHI 65.9 (56.45‐73.35) and TcCO 2 (mmHg) 65.70 (61.95‐67.30) vs. post‐NPA median (IQR) SpO 2 : 97.1% (96.19–97.9), AHI: 12.20 (11.25‐24.35), OAHI 10.20 (6.12‐5.62) and TcCO 2 (mmHg) 52.40 (47.90‐58.40)].
Conclusion
Our findings highlight the effectiveness and safety of NPA as a noninvasive management option for severe upper airway obstruction in children, particularly in those with anatomical midface structural differences. Further research and larger studies are warranted to confirm these findings and optimise management strategies for these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Paediatric Respiratory and Sleep Medicine, Queensland Children's Hospital, South Brisbane, Australia.
- Children's Health Queensland Clinical Unit, Faculty of Medicine, The University of Queensland, South Brisbane, Australia.
Zitieren
APA
Thambar, S., Wong, M. D., Schilling, S., & Kapur, N. (2024). Role of Nasopharyngeal Airway in Management of Craniofacial Syndrome‐Associated Upper Airway Obstruction in Children. Orthodontics & Craniofacial Research. https://doi.org/10.1111/ocr.12872
Vancouver
Thambar S, Wong MD, Schilling S, Kapur N. Role of Nasopharyngeal Airway in Management of Craniofacial Syndrome‐Associated Upper Airway Obstruction in Children. Orthodontics & Craniofacial Research. 2024. doi:10.1111/ocr.12872
BibTeX
@article{Thambar2024,
author = {Thambar, Samara and Wong, Matthew D and Schilling, Sandra and Kapur, Nitin},
title = {Role of Nasopharyngeal Airway in Management of Craniofacial Syndrome‐Associated Upper Airway Obstruction in Children},
journal = {Orthodontics & Craniofacial Research},
year = {2024},
doi = {10.1111/ocr.12872}
}
EUVIMED